Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tirzepatide is a dual agonist meaning it targets both GLP-1 and GIP receptors
doi: 10.1038/s41419-021-03880-9
Liver tissue was fixed in 4% paraformaldehyde (PFA) and routinely processed for paraffin-embedding and cross-sectioned to obtain 5 mthick sections
Mcgill J Med 2009;12:51PubMedPMC 20
Conceivably, those at risk for T2DM, persons with prediabetes and the metabolic syndrome, could be treated with GLP-1 therapy or better yet, a gene therapy to increase GLP-1 expression in the gastrointestinal tract
US$ 29.49
US$ 26.36
US$ 27.07
US$ 27.81
